Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
GeneTether Therapeutics Inc
C.GTTX
Healthcare
GeneTether Therapeutics Inc. is a Canada-based genetic medicines company focused on creating gene editing therapies based on its proprietary GeneTether platform. The Company's platform technology uses a proprietary method to tether donor deoxyribonucleic acid (DNA) templates to the genome editing complex, making the template readily available for use during the genome editing repair stage. By...
positioning a donor DNA template directly at the site of a double strand break, the Company's GeneTether platform drives the DNA repair process towards homology-directed repair (HDR), a cellular repair mechanism that incorporates the genetic information of a DNA template. It is building a discovery pipeline focused on the treatment of rare, monogenic diseases of the kidney and the skin. The Company's GeneTether platform may also allow for high fidelity engineering of cells to permanently deliver the therapeutic proteins necessary to treat certain genetic diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:GTTX)
New Post
View:
Posts & Comments
Threaded Posts
(19)
•••
CashFlowReality
X
Comment by
CashFlowReality
on Nov 21, 2024 10:11am
RE:300% share price increase
look at 16th October news release
(14)
•••
ElBorto
X
Post by
ElBorto
on Nov 20, 2024 4:17pm
300% share price increase
Anyone know what's driving the share price right now?
(19)
•••
CashFlowReality
X
Comment by
CashFlowReality
on Oct 31, 2024 1:21pm
RE:Look for the share price to start rising...
Time to buy!
(19)
•••
CashFlowReality
X
Post by
CashFlowReality
on Oct 16, 2024 6:13pm
Look for the share price to start rising...
GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue Sarcoma Drug Candidate .. basically, this is good news!!!
(19)
•••
CashFlowReality
X
Post by
CashFlowReality
on Aug 27, 2024 12:00pm
looking for more details on what the other possibilities are
NRs welcome (too)! e.g., is something brewing (or not)?
(19)
•••
CashFlowReality
X
Post by
CashFlowReality
on Mar 12, 2024 3:19pm
Yeap ... people are buying at 0.05
This might pop positive soon... just speculating here (but I do see valuations in the 0.05 range).
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 30, 2023 1:31pm
BUY BUY BUY BUY BUY
NOW IS THAT TIME
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 30, 2023 1:30pm
Real stock price share value
0.05$
(29)
•••
Vikingstock
X
Post by
Vikingstock
on Jan 12, 2023 2:52pm
2023 vs LY
Anyone see value here now at these prices below 10cents? Given how the original investors have taken a beating from launch, must be some very unhappy shareholders, but what's the way forward for
...more
(19)
•••
CashFlowReality
X
Post by
CashFlowReality
on Nov 17, 2022 11:09am
Small CAP "bio" no coming in vogue
Get ready for a run in "small caps" especially in bio-tech sector. GTTX could be one of them on their way up! GLTA
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?